These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 16231848)

  • 21. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    N Engl J Med; 2002 Feb; 346(8):564-9. PubMed ID: 11856795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
    Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monoclonal gammopathies of undetermined significance].
    Ifrah N; Zandecki M
    Rev Prat; 2006 Jan; 56(1):18-24. PubMed ID: 16548245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
    J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
    Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
    Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S; Kyle RA; Dyck PJ
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
    Semin Oncol; 2003 Apr; 30(2):169-71. PubMed ID: 12720130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal gammopathy of undetermined significance (MGUS).
    Kyle RA
    Baillieres Clin Haematol; 1995 Dec; 8(4):761-81. PubMed ID: 8845571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
    Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases].
    Mseddi-Hdiji S; Haddouk S; Ben Ayed M; Tahri N; Elloumi M; Baklouti S; Hachicha J; Krichen MS; Bahloul Z; Masmoudi H
    Pathol Biol (Paris); 2005 Feb; 53(1):19-25. PubMed ID: 15620605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia.
    Gertz MA; Kyle RA; Noel P
    J Clin Oncol; 1993 May; 11(5):914-20. PubMed ID: 8487054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
    Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
    Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.